UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifungal Susceptibility Testing: Current Approaches

Clinical microbiology reviews, 2020-06, Vol.33 (3)

2020

Volltextzugriff (PDF)

Fluconazole resistance in Candida species: a current perspective

Infection and drug resistance, 2017-01, Vol.10, p.237-245

2017

Volltextzugriff (PDF)

Candida auris: The recent emergence of a multidrug-resistant fungal pathogen

Medical mycology (Oxford), 2019-01, Vol.57 (1), p.1-12

2019

Volltextzugriff (PDF)

Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

Nature communications, 2018-12, Vol.9 (1), p.5346-13, Article 5346

2018

Volltextzugriff (PDF)

In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Diagnostic microbiology and infectious disease, 2018-03, Vol.90 (3), p.196-197

2018

Volltextzugriff (PDF)

Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species

Frontiers in microbiology, 2017-01, Vol.7, p.2173-2173

2017

Volltextzugriff (PDF)

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Clinical infectious diseases, 2017-01, Vol.64 (2), p.134-140

2017

Volltextzugriff (PDF)

Activity of novel antifungal compound APX001A against a large collection of Candida auris

Journal of antimicrobial chemotherapy, 2018-11, Vol.73 (11), p.3060-3062

2018

Volltextzugriff (PDF)

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance

Clinical infectious diseases, 2019-01, Vol.68 (1), p.15-21

2019

Volltextzugriff (PDF)

In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations

Antimicrobial agents and chemotherapy, 2019-11, Vol.63 (11)

2019

Volltextzugriff (PDF)

Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans

Eukaryotic Cell, 2012-10, Vol.11 (10), p.1289-1299

2012

Volltextzugriff (PDF)

Antifungal activity of nikkomycin Z against Candida auris

Journal of antimicrobial chemotherapy, 2021-05, Vol.76 (6), p.1495-1497

2021

Volltextzugriff (PDF)

Detection of TR34/L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Volltextzugriff (PDF)

Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

mBio, 2020-05, Vol.11 (3)

2020

Volltextzugriff (PDF)

Molecular Epidemiology of Blastomyces gilchristii Clusters, Minnesota, USA

Emerging infectious diseases, 2022-09, Vol.28 (9), p.1924-1926

2022

Volltextzugriff (PDF)

Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study

Journal of clinical microbiology, 2019-11, Vol.57 (11)

2019

Volltextzugriff (PDF)

Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance

Antimicrobial agents and chemotherapy, 2022-07, Vol.66 (7), p.e0028922-e0028922

2022

Volltextzugriff (PDF)

Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method

Journal of clinical microbiology, 2021-03, Vol.59 (4)

2021

Volltextzugriff (PDF)

Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States

mBio, 2021-08, Vol.12 (4), p.e0180321

2021

Volltextzugriff (PDF)

In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

Journal of fungi (Basel), 2021-05, Vol.7 (5), p.378

2021

Volltextzugriff (PDF)

Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis

Antimicrobial agents and chemotherapy, 2015-10, Vol.59 (10), p.5942-5950

2015

Volltextzugriff (PDF)

In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans

Microbiology spectrum, 2023-02, Vol.11 (1), p.e0278922-e0278922

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Englisch
(79)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antifungal Susceptibility Testing: Current Approaches

Fluconazole resistance in Candida species: a current perspective

Candida auris: The recent emergence of a multidrug-resistant fungal pathogen

Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Azole Antifungal Resistance in Candida albicans and Emerging Non- albicans Candida Species

Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Activity of novel antifungal compound APX001A against a large collection of Candida auris

Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance

In Vitro Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with FKS Mutations

Gain-of-Function Mutations in UPC2 Are a Frequent Cause of ERG11 Upregulation in Azole-Resistant Clinical Isolates of Candida albicans

Antifungal activity of nikkomycin Z against Candida auris

Detection of TR34/L98H CYP51A Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017

Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

Molecular Epidemiology of Blastomyces gilchristii Clusters, Minnesota, USA

Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study

Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole Resistance

Categorizing Susceptibility of Clinical Isolates of Candida auris to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method

Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States

In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis

In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans

Suchergebnisse filtern